COT Meeting: 16th May 2023

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 16th May 2023

Last updated: 28 July 2023

1.    Apologies for absence.

2.     Draft minutes and reserved minutes of the 28th March meeting TOX/MIN/2023/02.  

3.    Matters arising.

4.    Can coating  (Reserved) TOX/2023/23.

5.    EFSA opinion on BPA TOX/2023/25.

6.    Second draft statement on green tea catechins TOX/2023/26.

7.    Discussion paper on novel formulations of supplement compounds designed to increase oral bioavailability TOX/2023/27.                         

8.    Committee Advice on the safety of the extension of use of steviol glycosides (E 960) from stevia leaf extract produced by enzymatic conversion (RP1084) (Reserved) TOX/2023/28. 

9. Committee Advice on the safety of the Approval of Steviol Glycosides (E 960) Produced by Yarrowia lipolytica (RP1140) (Reserved) TOX/2023/29.

10. Update on the work of other FSA Scientific Advisory Committees - for information TOX/2023/30.                      

11. Any other business.

Next meeting of the Committee – Tuesday 11th July at Broadway House, London and via Teams.

Matters arising:

  • JEG update.
  • 3rd draft roadmap TOX/2023/22.

Media discussed during the meeting

PDF documents on this page are not in a fully accessible format, if you require it to be fully accessible, please see the HTML link for that document.


Draft minutes of the 28th March 2023 meeting


UK New Approach Methodologies Roadmap (2023) Draft Version 3




EFSA 2023 re-evaluation of the risk to public health from bisphenol A (BPA) in foodstuffs


Third Draft Statement on the Hepatotoxicity of Green Tea Catechins


Discussion Paper on Novel Formulations of Supplement Compounds Designed to Increase Oral Bioavailability






Update on the work of other Scientific Advisory Committees-May 2023

Final minutes of the meeting:

Final Minutes of the 16th May 2023 COT Meeting